Aclidinium inhibits proliferation and metastasis of ovarian cancer SKOV3 cells via downregulating PI3K/AKT/mTOR signaling pathway

Aclidinium, a muscarinic antagonist, is generally used to treat the respiratory system diseases whereas it is not clear whether aclidinium has therapeutic effect in ovarian cancer (OC). The aim of this study was to investigate the impact of aclidinium on OC and its potential mechanism. CCK-8 was emp...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Juan, Wang, Wei-Jing, Zhang, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202542/
https://www.ncbi.nlm.nih.gov/pubmed/30405778
http://dx.doi.org/10.3892/ol.2018.9460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202542/
https://www.ncbi.nlm.nih.gov/pubmed/30405778
http://dx.doi.org/10.3892/ol.2018.9460

Ejemplares similares